“Genomic Convergence of COVID-19 and Psoriatic Arthritis: Shared Inflammatory Pathways, Post-Viral Autoimmunity, and Therapeutic Implications”

John Murphy, CEO COVID-19 Long-haul Foundation Background: COVID-19 and psoriatic arthritis (PsA) are distinct clinical entities, yet emerging evidence suggests a convergence in their immunogenomic architecture. SARS-CoV-2 infection has been…[...]

Read More

COVID-19 and the Emergence of Post-Infectious Arthritis: Mechanisms, Diagnostics, and Therapeutic Outlook

John Murphy, CEO The COVID-19 Long-haul Foundation The COVID-19 pandemic has revealed a spectrum of post-infectious sequelae, among which inflammatory arthritis has emerged as a clinically relevant concern. While SARS-CoV-2…[...]

Read More

Persistent Expression and Systemic Distribution of mRNA COVID-19 Biologics: A Critical Review of Clinical, Genomic, and Immunological Implications

Author: John Murphy et al. Affiliation: Strategic Clinical Research Group, USVI & Pennsylvania Corresponding Author: John Murphy Abstract Messenger RNA (mRNA) biologics developed for SARS-CoV-2 have been widely deployed under…[...]

Read More

COVID-19 Vaccination and Rhabdomyolysis: Mechanistic Hypotheses, and Clinical Implications

Introduction The global deployment of COVID-19 vaccines has been instrumental in reducing morbidity and mortality associated with SARS-CoV-2. Among the most widely adopted platforms—mRNA-based vaccines such as BNT162b2 (Pfizer-BioNTech) and…[...]

Read More

🧠 Surgical Risk in the Era of Long COVID: A Converging Crisis in Perioperative Medicine

John Murphy, The COVID Long-haul Foundation Abstract As long COVID emerges as a persistent clinical syndrome affecting millions globally, its implications for surgical outcomes are increasingly evident. This article synthesizes…[...]

Read More